United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - rasburicase - powder and solvent for solution for infusion - 7.5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rasburicase -

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi aventis france, france - rasburicase - powder and solvent for solution for infusion - 7.5 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi aventis france, france - rasburicase - powder and solvent for solution for infusion - 1.5 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

uniquelaser assets pty ltd - 45220 - multi-modality skin surface treatment system - the leaseir technologies medical mhr diode laser equipment is conceived and designed for the reduction of unwanted hair or their removal through the emission of an infrared beam in impulses. it is intended for hair removal, dermatology procedures, the treatment of vascular lesions, such as telangiectasia and other benign vascular lesions, leg veins, and treatment of pseudofolliculitis barbae and hirsutism.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

f. hoffmann-la roche ltd. 4303 kaiseraugst- batch releaser - obinutuzumab - concentrate for solution for infusion - 1000mg/40ml

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - obinutuzumab - concentrate for solution for infusion - obinutuzumab 1000 mg / 40 ml - obinutuzumab - chronic lymphocytic leukaemia (cll)gazyva, in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll).follicular lymphoma (fl )gazyva, in combination with bendamustine followed by gazyva monotherapy, is indicated for the treatment of patients with follicular lymphoma (fl) who did not respond or who progressed during or up to 6 months after treatment with a rituximab-containing regimen.gazyva in combination with chemotherapy, followed by gazyva maintenance therapy in patients achieving a response, is indicated for the treatment of patients with previously untreated advanced follicular lymphoma.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

f. hoffmann-la roche ltd. 4303 kaiseraugs- secondary packager - obinutuzumab - concentrate for solution for infusion - 1000mg/40ml

Kenya - English - Pharmacy and Poisons Board

bottu s.a laboratories 82 casaurinas street, casablanca, morocco - azithromycin dihydrate usp equivalent to… - film-coated tablet - azithromycin dihydrate usp 524 mg equivalent to… - azithromycin

Kenya - English - Pharmacy and Poisons Board

bottu s.a laboratories 82 casaurinas street, casablanca, morocco - prednisolone (as sodium metasulphobenzoate) - effervescent tablet - 20mg - prednisolone